Effects of Rapamycin Combined with Cisplatin on Tumor Necrosis Factor TNF-α in MG-63 Cells

Rapamycin (RAPA) and cisplatin (CDDP) are used as clinical drugs in the treatment of various tumors, but there are few studies on the combination of RAPA and CDDP. Tumor necrosis factor α (TNF-α) plays an important role in tumorigenesis and development. This study is to explore the effects of RAPA c...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Tian-Yu, Ma, Bin, Hu, Bing, Xiang, Liang-Bi, Liu, Xin-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Cancer Pharmacogenomics and Target Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563936/
https://www.ncbi.nlm.nih.gov/pubmed/32686984
http://dx.doi.org/10.1177/0963689720926153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563936/
https://www.ncbi.nlm.nih.gov/pubmed/32686984
http://dx.doi.org/10.1177/0963689720926153

Ejemplares similares